A detailed history of Wolff Wiese Magana LLC transactions in Viatris Inc stock. As of the latest transaction made, Wolff Wiese Magana LLC holds 83 shares of VTRS stock, worth $1,039. This represents 0.0% of its overall portfolio holdings.

Number of Shares
83
Previous 83 -0.0%
Holding current value
$1,039
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

BUY
$10.05 - $12.02 $60 - $72
6 Added 7.79%
83 $0
Q3 2023

Oct 30, 2023

SELL
$9.59 - $11.35 $76 - $90
-8 Reduced 9.41%
77 $0
Q2 2023

Aug 01, 2023

SELL
$9.02 - $10.29 $180 - $205
-20 Reduced 19.05%
85 $0
Q1 2023

Apr 18, 2023

SELL
$9.2 - $12.26 $36 - $49
-4 Reduced 3.67%
105 $1,000
Q4 2022

Feb 08, 2023

SELL
$8.72 - $11.56 $23,151 - $30,691
-2,655 Reduced 96.06%
109 $1,000
Q3 2022

Oct 26, 2022

BUY
$8.48 - $11.13 $424 - $556
50 Added 1.84%
2,764 $23,000
Q2 2022

Jul 15, 2022

SELL
$9.95 - $12.27 $825 - $1,018
-83 Reduced 2.97%
2,714 $28,000
Q1 2022

May 09, 2022

BUY
$9.81 - $15.4 $6,670 - $10,472
680 Added 32.12%
2,797 $30,000
Q4 2021

Jan 18, 2022

SELL
$12.09 - $14.68 $1,753 - $2,128
-145 Reduced 6.41%
2,117 $29,000
Q3 2021

Oct 15, 2021

SELL
$13.25 - $15.13 $384 - $438
-29 Reduced 1.27%
2,262 $31,000
Q2 2021

Jul 15, 2021

SELL
$12.97 - $16.15 $39,415 - $49,079
-3,039 Reduced 57.02%
2,291 $33,000
Q1 2021

Apr 15, 2021

BUY
$13.59 - $18.54 $15,438 - $21,061
1,136 Added 27.09%
5,330 $75,000
Q4 2020

Jan 27, 2021

BUY
$14.3 - $18.74 $59,974 - $78,595
4,194 New
4,194 $79,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Wolff Wiese Magana LLC Portfolio

Follow Wolff Wiese Magana LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolff Wiese Magana LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolff Wiese Magana LLC with notifications on news.